ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACHV Achieve Life Sciences Inc

4.575
0.035 (0.77%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Achieve Life Sciences Inc ACHV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.035 0.77% 4.575 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.47 4.43 4.66 4.575 4.54
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/25/202408:00GLOBEAchieve Life Sciences to Announce First Quarter Financial..
4/11/202408:00GLOBEAchieve Life Sciences to Present at Life Science Innovation..
3/28/202416:01GLOBEAchieve Life Sciences Reports Financial Results for Fourth..
3/20/202408:00GLOBEAchieve Life Sciences Announces Data from Cytisinicline ORCA..
3/14/202408:00GLOBEAchieve Life Sciences to Announce Fourth Quarter and..
3/06/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:41EDGAR2Form 8-K - Current report
2/29/202416:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/29/202408:01GLOBEAchieve Life Sciences Reaches Agreement with the FDA on..
2/29/202408:00GLOBEAchieve Life Sciences Announces Pricing of up to $124.2..
2/27/202415:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/29/202414:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202419:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202419:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202419:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202316:04EDGAR2Form 8-K - Current report
11/09/202316:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:00GLOBEAchieve Life Sciences Reports Financial Results for Third..
10/26/202308:00GLOBEAchieve Life Sciences to Announce Third Quarter 2023..
10/03/202308:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
9/11/202308:00GLOBEAchieve Life Sciences Announces Presentation of..
9/07/202308:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
8/14/202316:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202316:06EDGAR2Form 8-K - Current report
8/14/202316:00GLOBEAchieve Life Sciences Reports Financial Results for Second..
8/01/202308:00GLOBEAchieve Life Sciences to Announce Second Quarter 2023..
7/18/202308:00GLOBEAchieve Life Sciences Announces Presentation at 2023..
7/11/202311:23GLOBEAchieve Life Sciences Announces Publication of Cytisinicline..
6/06/202308:00GLOBEAchieve Life Sciences Announces Participation at Upcoming..
5/25/202309:00GLOBEAchieve Life Sciences Announces Pricing of $16.5 Million..
5/23/202306:00GLOBEAchieve Life Sciences Reports Statistically Significant..
5/17/202308:00GLOBEAchieve Life Sciences Announces Refinancing of Outstanding..
5/09/202316:05GLOBEAchieve Life Sciences Reports Financial Results for First..

Your Recent History

Delayed Upgrade Clock